Dear Partners and Future Partners, In recent months, StarkAge Therapeutics has achieved remarkable milestones. Exceptional results in the efficacy and safety of STX-1, combined with a strengthened governance, have propelled us into a new phase of growth. These accomplishments would not have been possible without our successful fundraising earlier this year. We extend our sincere gratitude to our new shareholders for their trust and support.